JP5955494B2 - １，２，４−オキサジアゾール安息香酸の製造方法 - Google Patents

１，２，４−オキサジアゾール安息香酸の製造方法 Download PDF

Info

Publication number
JP5955494B2
JP5955494B2 JP2009527430A JP2009527430A JP5955494B2 JP 5955494 B2 JP5955494 B2 JP 5955494B2 JP 2009527430 A JP2009527430 A JP 2009527430A JP 2009527430 A JP2009527430 A JP 2009527430A JP 5955494 B2 JP5955494 B2 JP 5955494B2
Authority
JP
Japan
Prior art keywords
another embodiment
batch
steps
butanol
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009527430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502715A (ja
JP2010502715A5 (enExample
Inventor
ジー．アルムステアド ネイル
ジー．アルムステアド ネイル
セオングウォオ フワング ペテル
セオングウォオ フワング ペテル
ピネス セエモン
ピネス セエモン
モオン ヨウング‐チョオン
モオン ヨウング‐チョオン
ジェイ．タカスギ ジェアメス
ジェイ．タカスギ ジェアメス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PTC Therapeutics Inc
Original Assignee
PTC Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PTC Therapeutics Inc filed Critical PTC Therapeutics Inc
Publication of JP2010502715A publication Critical patent/JP2010502715A/ja
Publication of JP2010502715A5 publication Critical patent/JP2010502715A5/ja
Application granted granted Critical
Publication of JP5955494B2 publication Critical patent/JP5955494B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2009527430A 2006-09-08 2007-09-06 １，２，４−オキサジアゾール安息香酸の製造方法 Active JP5955494B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84359506P 2006-09-08 2006-09-08
US60/843,595 2006-09-08
PCT/US2007/019561 WO2008030570A1 (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014103966A Division JP2014193896A (ja) 2006-09-08 2014-05-20 １，２，４−オキサジアゾール安息香酸の製造方法

Publications (3)

Publication Number Publication Date
JP2010502715A JP2010502715A (ja) 2010-01-28
JP2010502715A5 JP2010502715A5 (enExample) 2010-10-21
JP5955494B2 true JP5955494B2 (ja) 2016-07-20

Family

ID=38935880

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009527430A Active JP5955494B2 (ja) 2006-09-08 2007-09-06 １，２，４−オキサジアゾール安息香酸の製造方法
JP2014103966A Pending JP2014193896A (ja) 2006-09-08 2014-05-20 １，２，４−オキサジアゾール安息香酸の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014103966A Pending JP2014193896A (ja) 2006-09-08 2014-05-20 １，２，４−オキサジアゾール安息香酸の製造方法

Country Status (24)

Country Link
US (2) US7678922B2 (enExample)
EP (1) EP2059513B1 (enExample)
JP (2) JP5955494B2 (enExample)
KR (1) KR101466368B1 (enExample)
CN (1) CN101535284B (enExample)
AR (3) AR062715A1 (enExample)
AU (1) AU2007292915B2 (enExample)
BR (1) BRPI0716996B8 (enExample)
CA (2) CA2662749C (enExample)
CL (1) CL2007002606A1 (enExample)
DK (1) DK2059513T3 (enExample)
ES (1) ES2404348T3 (enExample)
IL (1) IL197445A (enExample)
MX (1) MX2009002439A (enExample)
MY (1) MY148598A (enExample)
NZ (2) NZ598012A (enExample)
PE (2) PE20080771A1 (enExample)
PL (1) PL2059513T3 (enExample)
PT (1) PT2059513E (enExample)
RU (1) RU2495030C2 (enExample)
TW (1) TWI482761B (enExample)
UA (1) UA99265C2 (enExample)
WO (1) WO2008030570A1 (enExample)
ZA (1) ZA200901782B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2910551T3 (pl) 2003-04-11 2017-09-29 Ptc Therapeutics, Inc. Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
PT2402002T (pt) 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
CA2647903C (en) 2006-03-30 2016-12-13 Ptc Therapeutics, Inc. Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
WO2008030570A1 (en) * 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids
EP2068871B1 (en) 2006-09-25 2013-12-25 PTC Therapeutics, Inc. Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
SI2076501T1 (sl) * 2006-09-25 2016-05-31 Ptc Therapeutics, Inc. Kristalinične oblike 3-(5-(2-florofenil)-1,2,4) oksadiazol-3-il)-benzojske kisline
ES2538359T3 (es) 2006-10-12 2015-06-19 Ptc Therapeutics, Inc. Métodos para administrar un 1,2,4-oxadiazol activo por vía oral para terapia de supresión de mutación sin sentido
CN101714009A (zh) * 2009-05-14 2010-05-26 翁印嵩 集成通用电话功能的计算机
ES2610362T3 (es) 2011-01-25 2017-04-27 Viviabiotech, S.L. Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1
UA114915C2 (uk) 2012-07-02 2017-08-28 Монсанто Текнолоджи Ллс Спосіб одержання 3,5-дизаміщених 1,2,4-оксадіазолів (варіанти)
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 １,２,４-二唑苯甲酸之鹽及醫藥組合物
CN105461650B (zh) * 2014-09-12 2018-04-13 杭州普晒医药科技有限公司 一种噁二唑化合物的溶剂化物及其制备方法
CN106316885B (zh) * 2015-07-03 2019-02-12 普济生物科技（台州）有限公司 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
MX2018005361A (es) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Metodos para tratar epilepsia.
TW201808922A (zh) 2016-06-20 2018-03-16 台灣神隆股份有限公司 製備阿塔魯仁及其中間體的方法
US12268669B2 (en) 2018-12-20 2025-04-08 Pfizer Inc. Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent
EA202192767A1 (ru) 2019-04-10 2021-12-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ лечения опосредуемой нонсенс-мутацией мышечной дистрофии дюшенна у педиатрических пациентов
WO2022112919A1 (en) 2020-11-25 2022-06-02 Pfizer Inc. (aza)benzothiazolyl substituted pyrazole compounds
CN113045510B (zh) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 一种阿塔鲁伦的制备方法
CN114920667B (zh) * 2022-06-30 2024-06-21 湖南大学 一种阿塔鲁伦酯的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DE4425794A1 (de) * 1994-07-21 1996-01-25 Basf Ag Nitrofarbstoffe
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CA2449544A1 (en) * 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
MY151199A (en) * 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
US20040132726A1 (en) * 2002-08-09 2004-07-08 Astrazeneca Ab And Nps Pharmaceuticals, Inc. New compounds
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
PL2910551T3 (pl) * 2003-04-11 2017-09-29 Ptc Therapeutics, Inc. Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
US20050075375A1 (en) * 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
PT2402002T (pt) * 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
WO2008030570A1 (en) * 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Also Published As

Publication number Publication date
PL2059513T3 (pl) 2013-06-28
WO2008030570A1 (en) 2008-03-13
UA99265C2 (ru) 2012-08-10
TWI482761B (zh) 2015-05-01
DK2059513T3 (da) 2013-05-06
ZA200901782B (en) 2010-06-30
AR062715A1 (es) 2008-11-26
CA2662749A1 (en) 2008-03-13
US8367841B2 (en) 2013-02-05
JP2010502715A (ja) 2010-01-28
CA2842625C (en) 2016-07-12
RU2495030C2 (ru) 2013-10-10
AR118922A2 (es) 2021-11-10
EP2059513B1 (en) 2013-01-23
EP2059513A1 (en) 2009-05-20
PT2059513E (pt) 2013-04-30
BRPI0716996A2 (pt) 2013-10-08
CA2842625A1 (en) 2008-03-13
IL197445A (en) 2014-01-30
AU2007292915A1 (en) 2008-03-13
TW200823180A (en) 2008-06-01
PE20080771A1 (es) 2008-06-13
ES2404348T3 (es) 2013-05-27
AU2007292915B2 (en) 2012-07-26
AR107474A2 (es) 2018-05-02
BRPI0716996B1 (pt) 2021-02-09
US20080139818A1 (en) 2008-06-12
NZ598012A (en) 2013-08-30
CL2007002606A1 (es) 2008-04-18
MY148598A (en) 2013-05-15
US7678922B2 (en) 2010-03-16
CN101535284A (zh) 2009-09-16
US20100063297A1 (en) 2010-03-11
KR101466368B1 (ko) 2014-11-27
MX2009002439A (es) 2009-03-27
HK1134094A1 (en) 2010-04-16
NZ575511A (en) 2012-02-24
RU2009113019A (ru) 2010-10-20
CA2662749C (en) 2015-01-20
PE20120669A1 (es) 2012-06-01
JP2014193896A (ja) 2014-10-09
CN101535284B (zh) 2014-12-10
BRPI0716996B8 (pt) 2021-05-25
KR20090054464A (ko) 2009-05-29
IL197445A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
JP5955494B2 (ja) １，２，４−オキサジアゾール安息香酸の製造方法
US9126988B2 (en) Intermediate for preparing a catechol-O-methyltransferase inhibitor
MX2010009162A (es) Moduladores selectivos del receptor de androgeno.
JP2019523273A (ja) ベリノスタットの多形形態、およびその調製のためのプロセス
JP2004504319A (ja) ４−フェニルピペリジン誘導体の新規製造方法
WO2013072923A1 (en) Process for the preparation of crystalline linezolid
US12060345B2 (en) Process for preparing a phthalazinone derivative and intermediates thereof
CN102639498A (zh) 制备2-(1-苯乙基)异吲哚啉-1-酮化合物的方法
HK1134094B (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
CN103119040A (zh) 制备利奈唑胺的方法
JP2024503423A (ja) 脂質を生産するための方法
WO2016020403A1 (en) Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
US20060178519A1 (en) Process for preparing tegaserod
CN102304125A (zh) 一种用于制备利奈唑胺的中间体
EP2765131B1 (en) Process for the production of Moxonidine
EP2917189B1 (en) Process for making linezolid
CN114829337A (zh) 1-（4-苄氧基-苄基）-3-甲基-硫脲的新型晶型的制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100902

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100902

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121211

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130412

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130419

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130712

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130716

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140121

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160615

R150 Certificate of patent or registration of utility model

Ref document number: 5955494

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250